Showing results (51-60 of 198) with videos related to

Sort By:
Pageof 20
Frontiers in Pediatrics|July 23, 2021
The Improved Prognosis of Hypoplastic Left Heart: A Population-Based Register Study of 343 Cases in England and WalesKate E Best, Nicola Miller, Elizabeth Draper, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 9, 2013
Non-battle craniomaxillofacial injuries from U.S. military operationsAndrew Q Madson, David Tucker, Jay Aden, et al.
British Journal of Haematology|February 4, 2020
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapyRory McCulloch, Carlo Visco, Toby A Eyre, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
British Journal of Haematology|December 19, 2018
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphomaSimon Rule, Gordon Cook, Nigel H Russell, et al.
Journal of Animal Science|August 21, 2020
Genomic predictions for enteric methane production are improved by metabolome and microbiome data in sheep (Ovis aries)Elizabeth M Ross, Ben J Hayes, David Tucker, et al.
Asian Pacific Journal of Tropical Disease|February 16, 2016
Physician perceptions of HIV cure in China: A mixed methods review and implications for HIV cure researchZachary Clarke Rich, Chuncheng Liu, Qingyan Ma, et al.
Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.
Pageof 20